Therapy of cancer by cytokines mediated by gene therapy approach | |
Qian, C; Liu, XY; Prieto, J | |
刊名 | CELL RESEARCH |
2006 | |
卷号 | 16期号:2页码:182-188 |
关键词 | gene therapy cancer cytokines vectors adenovirus |
通讯作者 | Qian, C (reprint author), Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Sch Life Sci, Hangzhou, Peoples R China.,cqian@unav.es |
英文摘要 | Gene therapy offers a new approach for treatment of cancer. Transfer of genes encoding immunostimulatory cytokines has been used with remarkable success to eliminate cancer in animals. However, clinical trials in patients with this strategy had limited efficacy. Therefore, improvement of gene transfer vector system is necessary. A hybrid viral vector, consisting of SFV replicon with either murine IL-12 or reporter LacZ gene, was constructed. This hybrid vector showed specificity and high level of expression in HCC both in vitro and in vivo. In a rat orthotropic liver tumor model, treatment of established tumors by the hybrid vector with mIL-12 gene resulted in a strong anti-tumor activity without accompanying toxicity. Subsequently, a helper-dependent adenovirus vectors containing a mifepristone (RU486) inducible system was constructed for controlled and liver-specific expression of human interleukin 12 (hIL-12) (HD-Ad/RUhIL-12) and mouse IL-12 (mIL-12) (HD-Ad/RUinIL-12). Data showed that high and sustained serum levels of hIL-12 could be attained by continuing administration of RU486 every 12 or 24 h. Repetitive induction of hIL-12 could be obtained over, at least, a period of 48 weeks after a single injection of HD-Ad/RUhIL-12. Treatment of liver metastases with of HD-Ad/RUmIL-12 plus RU846 resulted in complete tumor regression in all animals. Then, different cytokine genes were inserted into conditional replicative adenoviruses vectors (also called oncolytic adenovirus). Replication of adenovirus in tumor cells would kill tumor cells and release viruses, which infect surrounding tumor cells. The combination of cytopathic effect by oncolytic adenovirus and biological effect of transgene would exert strong antitumor activity. These new types of vectors may provide a potent and safe tool for cancer gene therapy. |
学科主题 | Cell Biology |
类目[WOS] | Cell Biology |
关键词[WOS] | ONCOLYTIC ADENOVIRAL VECTOR ; ENDOTHELIAL GROWTH-FACTOR ; EXPRESSION IN-VIVO ; HEPATOCELLULAR-CARCINOMA ; INTRATUMORAL INJECTION ; LIVER-CANCER ; PHASE-I ; TRANSGENE EXPRESSION ; ANTITUMOR IMMUNITY ; COLON-CANCER |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000237176900010 |
内容类型 | 期刊论文 |
版本 | 出版稿 |
源URL | [http://202.127.25.143/handle/331003/1670] |
专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
推荐引用方式 GB/T 7714 | Qian, C,Liu, XY,Prieto, J. Therapy of cancer by cytokines mediated by gene therapy approach[J]. CELL RESEARCH,2006,16(2):182-188. |
APA | Qian, C,Liu, XY,&Prieto, J.(2006).Therapy of cancer by cytokines mediated by gene therapy approach.CELL RESEARCH,16(2),182-188. |
MLA | Qian, C,et al."Therapy of cancer by cytokines mediated by gene therapy approach".CELL RESEARCH 16.2(2006):182-188. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论